New data from Pitt County Schools shows 81 students in the district are not up to date on their immunizations.

Zanzalintinib and atezolizumab improved overall survival in metastatic colorectal cancer compared to regorafenib, with a median OS of 10.9 vs 9.4 months. The combination showed progression-free ...

A new behavioral urgent health care facility in Pitt County will open its doors to the public next week. Today, the North ...

Discover ITT Inc.'s growth in revenue and profits, current valuation, and future outlook. Click for why a Hold rating is ...

Exelixis stock dips after Phase 3 data show modest survival gains from zanzalintinib and Tecentriq combo in colorectal cancer ...